Table 1 Effect of the tested drugs on BGL in alloxan-induced diabetic rats

Normal control group

136.5 ± 18.52

121.33 ± 12.08

119.25 ± 11.35

109 ± 10.92

Diabetic control group

359.75 ± 45.13*

328 ± 141.34*

428.5 ± 121.17*

396.5 ± 80.60*

Diabetic group treated with bromocriptine

191 ± 16.89^#

199.25 ± 65.05^#

238.25 ± 56.88^#

284.25 ± 148.00^#

Diabetic group treated with Cabergoline

213.75 ± 37.74^#

211.75 ± 38.62^#

293 ± 213.15^#

280.25 ± 220.48^#

Diabetic group treated with sarpogrelate

326.25 ± 93.45

298.25 ± 122.37

393.75 ± 118.77

369.75 ± 43.15

Diabetic group treated with bromocriptine + sarpogrelate

247.75 ± 50.35^#

215.5 ± 33.20^#

310.25 ± 70.59^#

288.25 ± 109.41^#

Diabetic group treated with cabergoline + sarpogrelate

196 ± 54.20^#

158.75 ± 35.01^#

235.5 ± 182.22^#

215.75 ± 141.46^#